| Literature DB >> 31781332 |
Jinlong Wei1, Bin Wang1, Huanhuan Wang1, Lingbin Meng2, Qin Zhao1, Xinyu Li1, Ying Xin3, Xin Jiang1.
Abstract
Radiotherapy (RT) is currently one of the leading treatments for various cancers; however, it may cause damage to healthy tissue, with both short-term and long-term side effects. Severe radiation-induced normal tissue damage (RINTD) frequently has a significant influence on the progress of RT and the survival and prognosis of patients. The redox system has been shown to play an important role in the early and late effects of RINTD. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are the main sources of RINTD. The free radicals produced by irradiation can upregulate several enzymes including nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase), lipoxygenases (LOXs), nitric oxide synthase (NOS), and cyclooxygenases (COXs). These enzymes are expressed in distinct ways in various cells, tissues, and organs and participate in the RINTD process through different regulatory mechanisms. In recent years, several studies have demonstrated that epigenetic modulators play an important role in the RINTD process. Epigenetic modifications primarily contain noncoding RNA regulation, histone modifications, and DNA methylation. In this article, we will review the role of oxidative stress and epigenetic mechanisms in radiation damage, and explore possible prophylactic and therapeutic strategies for RINTD.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31781332 PMCID: PMC6875293 DOI: 10.1155/2019/3010342
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1The mechanisms of redox system activation, inflammation response, and epigenetic regulation following exposure to radiation.
The epigenetic regulation in radiation-induced normal tissue damage.
| Epigenetic mechanisms | Irradiation organ | Epigenetic functions | Target genes/proteins | Damage effects | Reference |
|---|---|---|---|---|---|
| DNA methylation | Brain | Increased expression of DNMT1 and 3a | Increased expression of TET1 and TET3 proteins | Radiation-induced cognitive dysfunction | Acharya et al. [ |
| Thymus | Decreased expression of DNMT1, 3a, and 3b | Decrease in the levels of methyl-binding proteins MeCP2 and MBD2 | Increased the risk of radiation-inducedleukemia and thymic lymphoma | Pogribny et al. [ | |
| Human breast cancer cells (MDA-MB-231) | Decreased DNMT1 expression | Downregulation of RB1 expression | DNA damage and apoptosis | Antwih et al. [ | |
| Brain | Decreased expression of DNMT1, 3a, and 3b | Decrease in the levels of methyl-binding protein MeCP2 | Bystander effect in the spleen | Koturbash et al. [ | |
|
| |||||
| Histone methylation | Intestine | Increased expression of histone H3 methylation | — | Radiation-induced intestinal damage | Herberg et al. [ |
|
| |||||
| Histone acetylation | Skin | Inhibition of HDAC activity | — | Radiation-induced skin damage and carcinogenesis | Zhang et al. [ |
|
| |||||
| Regulation of miRNAs | Hematopoietic system | Upregulation of miR-30a-3p, miR-30c-5p, etc. | — | Radiation-induced hematopoietic damage | Acharya et al. [ |
| Lung | Upregulation of miR-19a-3p, miR-144-5p, and miR-144-3p | — | Radiation-induced lung injury | Gao et al. [ | |
| Spleen | Increased expression of miR-34a | Upregulation of gene p53 | Radiation-induced spleen damage | Ghosh et al. [ | |
| Hematopoietic and osteoblast cells | Increased expression of miR-30c | Suppression of gene REDD1 | Radiation-induced hematopoietic and osteoblast cell damage | Li et al. [ | |